Landscapes / Companies
Sierra Oncology LLC - a GSK company not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 3 in all
Trials
0 active
12 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Tyrosine kinase inhibitor |
Approved | 11 Dec 2026soonPhase 2 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 11 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis and 2 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021